Amsbio Introduces Synthetic Cell Mimics for Flow Cytometry
Amsbio has launched synthetic cell mimic controls for flow cytometry, aiming to improve lot-to-lot consistency and reproducibility in diagnostics and cell therapy manufacturing.
Read MorePosted by CLP Edit Staff | Aug 19, 2026 | Flow Cytometry Reagents & Test Kits |
Amsbio has launched synthetic cell mimic controls for flow cytometry, aiming to improve lot-to-lot consistency and reproducibility in diagnostics and cell therapy manufacturing.
Read MorePosted by CLP Edit Staff | Aug 18, 2026 | Anatomic Pathology |
Researchers from Peking Union Medical College Hospital have proposed a framework for agent-based AI systems to support clinical pathology workflows, detailing roles for intelligent agents in slide overview, diagnostic reasoning, and report generation.
Read MorePosted by CLP Edit Staff | Aug 17, 2026 | Digital Pathology, Histology, Molecular Diagnostics |
Researchers at CeMM and the Ludwig Boltzmann Institute have developed AI-based “tissue clocks” that estimate organ-specific biological age from blood samples, potentially improving chronic disease monitoring, according to a Nature Medicine study.
Read MorePosted by CLP Edit Staff | Aug 17, 2026 | Cancer, Digital Pathology, Histology |
Researchers have developed an AI model that analyzes whole slide histopathology images to predict TP53 mutations, cancer subtypes, and survival outcomes across 32 solid tumor types.
Read MorePosted by CLP Edit Staff | Aug 17, 2026 | Dementias & Alzheimer’s, Immunoassay |
The CLEAR-AD study found significant performance differences among nine commercial plasma p-tau217 assays for Alzheimer’s, underscoring the need for platform-specific calibration to ensure diagnostic accuracy.
Read More